Does Bile Acid Binding Resins Interact with Elafibranor?
Bile Acid Binding Resins and Elafibranor have a moderate drug interaction according to U.S. FDA drug labeling data. Bile acid sequestrants may reduce ELAFIBRANOR absorption and systemic exposure, decreasing efficacy. The mechanism involves interference with absorption and systemic exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Elafibranor Class
- Peroxisome Proliferator-activated Receptor Agonist
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Bile Acid Binding Resins and Elafibranor occurs because interference with absorption and systemic exposure. Clinically, this means bile acid sequestrants may reduce elafibranor absorption and systemic exposure, decreasing efficacy. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Bile Acid Binding Resins and your doctor is considering prescribing Elafibranor (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider